Efficacy Study of Azithromycin-based Therapy for Bronchiolitis Obliterans

NATerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Graft vs Host DiseaseBronchiolitis Obliterans
Interventions
DRUG

azithromycin + N-acetylcystein + inhaled corticosteroid

"* Azithromycin 500mg qd x 1 week --\> 250mg qod x 6 months~* N-acetylcystein 200mg tid x 6 months~* Fluticasone 250mcg puff x2/day x 6 months"

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT01327625 - Efficacy Study of Azithromycin-based Therapy for Bronchiolitis Obliterans | Biotech Hunter | Biotech Hunter